Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses
- 1 May 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 56 (5), 1080-1088
- https://doi.org/10.1016/j.jhep.2011.12.009
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic ModelsOncology, 2011
- Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort studyHepatology International, 2009
- Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survivalThe Esophagus, 2008
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)The Esophagus, 2003
- Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging systemCancer, 2002
- Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinomaHepatology, 2000
- A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patientsHepatology, 1998
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973